National Comprehensive Cancer Network

About The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Development and Update of the NCCN Guidelines
Recent Updates to NCCN Guidelines®
NCCN Guidelines Panels-Meeting Schedule
NCCN Categories of Evidence and Consensus
NCCN Guidelines® Steering Committee
Transparency: Process and Recommendations
Submission Request to the NCCN Guidelines Panels
Submission Request History
NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium® Chapters By Disease
Subscribe to the NCCN Compendium
No Longer Recommended Uses
JNCCN — Journal of the National Comprehensive Cancer Network

NCCN Guidelines® & Clinical Resources

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

Transparency: Process and Recommendations

These documents will open in a new browser window.




The recommendations regarding the uses and indications in the NCCN Drugs & Biologics Compendium® have been derived directly from the NCCN Clinical Practice Guidelines in Oncology® which are a statement of consensus of the authors with respect to the scientific evidence and their expert views of appropriate treatments for patients with cancer. The NCCN Compendium neither represents an all-inclusive listing of every drug and biologic nor every use and indication for Drugs & Biologics. The listing of Drugs & Biologics in the Compendium is limited in consideration to a discussion of the uses of Drugs & Biologics in cancer care. NCCN considers clinical trials participation to be appropriate care. Any clinician seeking to apply or consult the NCCN Compendium is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment.

NCCN Website Supporters